Katherine Stueland
CHIEF EXECUTIVE OFFICER at GeneDx Holdings. Based in Stamford, Connecticut.
- Rank
- 13249th of 14,452
- Companies held
- 1
- Largest holding
- WGS, 100.0% of total
- Latest SEC filing
- Sep 16, 2026
What the $5.7M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| GeneDx Holdings WGS Class A Common Stock | Directly | 115,476 | $49.24 | $5.7M | 100.0% | Form 4, Sep 16, 2026 |
Share counts are the amounts Katherine Stueland reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Sold | WGS | 4,141 | $98.27 | $407K | View |
| Sep 16, 2026 | Sold | WGS | 1,525 | $96.90 | $148K | View |
| Sep 16, 2026 | Sold | WGS | 148 | $95.41 | $14K | View |
| Sep 16, 2026 | Sold | WGS | 1,648 | $94.26 | $155K | View |
| Sep 16, 2026 | Sold | WGS | 3,039 | $99.00 | $301K | View |
| Sep 9, 2026 | Sold | WGS | 3,692 | $84.22 | $311K | View |
| Jun 16, 2026 | Sold | WGS | 5,932 | $60.83 | $361K | View |
| Jun 16, 2026 | Sold | WGS | 2,140 | $59.75 | $128K | View |
| Jun 16, 2026 | Sold | WGS | 2,429 | $61.50 | $149K | View |
| Jun 9, 2026 | Sold | WGS | 3,639 | $53.77 | $196K | View |
| Apr 29, 2026 | Sold | WGS | 2,154 | $65.20 | $140K | View |
| Apr 29, 2026 | Sold | WGS | 18 | $64.12 | $1K | View |
| Mar 26, 2026 | Sold | WGS | 5,117 | $62.33 | $319K | View |
| Mar 26, 2026 | Sold | WGS | 13,229 | $61.29 | $811K | View |
| Mar 26, 2026 | Sold | WGS | 9,883 | $65.21 | $644K | View |
| Mar 26, 2026 | Sold | WGS | 13,412 | $63.28 | $849K | View |
| Mar 26, 2026 | Sold | WGS | 5,292 | $64.60 | $342K | View |
| Mar 16, 2026 | Sold | WGS | 772 | $77.94 | $60K | View |
| Mar 16, 2026 | Sold | WGS | 9,229 | $77.05 | $711K | View |
| Mar 16, 2026 | Sold | WGS | 7,178 | $76.35 | $548K | View |
| Mar 9, 2026 | Sold | WGS | 3,678 | $86.75 | $319K | View |
| Mar 4, 2026 | Sold | WGS | 5,861 | $77.63 | $455K | View |
| Mar 4, 2026 | Sold | WGS | 10,465 | $78.61 | $823K | View |
| Mar 4, 2026 | Sold | WGS | 9,133 | $79.25 | $724K | View |
| Jan 29, 2026 | Sold | WGS | 1,653 | $94.00 | $155K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 13246 | Anthony Leon Wood Jr. Director, Cardinal Infrastructure Group. Raleigh, NC | $5.7M |
| 13247 | David C. Hodgson Director, Royalty Pharma. New York, NY | $5.7M |
| 13248 | Scott D. Hoffman CAO and General Counsel, Lazard. New York, NY | $5.7M |
| 13249 | Katherine Stueland CHIEF EXECUTIVE OFFICER, GeneDx Holdings. Stamford, CT | $5.7M |
| 13250 | Allegra S. Driscoll EVP, Chief Technology Officer, Bread Financial Holdings. Manhattan, NY | $5.7M |
| 13251 | Michael Smith Executive Vice President, McCormick & Company. Ewing, NJ | $5.7M |
| 13252 | Netha N. Johnson Chief Operations Officer, Albemarle. Minneapolis, MN | $5.7M |
Other GeneDx Holdings insiders
All WGS insiders- Icahn School Of Medicine At Mount Sinai$134M10% owner. #1200 overall
- Jason Ryan$12.8MDirector. #7283 overall
- Emily M. Leproust$1.2MDirector. #1870 overall
Questions
How much stock does Katherine Stueland own?
Katherine Stueland holds $5,686,038 in listed stock based on SEC filings and current prices, mostly GeneDx Holdings (WGS). That ranks 13249th on the Stock Rich List.
Is this Katherine Stueland's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Katherine Stueland last buy or sell stock?
The most recent open-market trade on file is a sale of 4,141 WGS shares on Sep 16, 2026 at $98.27.